Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages

Experimental and Molecular Medicine

Volumn 46, Issue 1, 2014, Pages

  Cho, Dong Im ^a   Kim, Mi Ra ^a   Jeong, Hye Yun ^a   Jeong, Hae Chang ^a   Jeong, Myung Ho ^a   Yoon, Sung Ho ^b   Kim, Yong Sook ^a   Ahn, Youngkeun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chosun University College of Medicine   (South Korea)

Author keywords

Immunologic environment; Macrophage; Mesenchymal stem cell; Myocardial infarction

Indexed keywords

ARGINASE 1; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MEMBRANE DEPOLARIZATION; CELL REGENERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVITY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; IMMUNOHISTOCHEMISTRY; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; RATS;

EID: 84896808531     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.135     Document Type: Article

References (27)

1. Freytes DO, Kang JW, Marcos-Campos I, Vunjak-Novakovic G. Macrophages modulate the viability and growth of human mesenchymal stem cells. J Cell Biochem 2013; 114: 220-229.
2. Nakajima H, Uchida K, Guerrero AR, Watanabe S, Sugita D, Takeura N et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma 2012; 29: 1614-1625.
3. Francois M, Romieu-Mourez R, Li M, Galipeau J. Human MSC suppression correlates with cytokine induction of indoleamine 2, 3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 2012; 20: 187-195.
4. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, Nepomnaschy I et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 2010; 5: e9252.
5. Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012; 2012: 948098.
6. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593-604.
7. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229: 176-185.
8. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122: 787-795.
9. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-555.
10. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunology 2005; 5: 953-964.
11. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
12. Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protocols 2009; 4: 102-106.
13. Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. Curr Protocols Immunol 2008. Chapter 14: Unit 14 1.
14. Weischenfeldt J, Porse B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protocols 2008; 3: 1-7.
15. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 2009; 37: 1445-1453.
16. Beda N, Nedospasov A. A spectrophotometric assay for nitrate in an excess of nitrite. Nitric Oxide Biol Chem 2005; 13: 93-97.
17. Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010; 121: 2437-2445.
18. Panizzi P, Swirski FK, Figueiredo JL, Waterman P, Sosnovik DE, Aikawa E et al. Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol 2010; 55: 1629-1638.
19. Lee WW, Marinelli B, van der Laan AM, Sena BF, Gorbatov R, Leuschner F et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol 2012; 59: 153-163.
20. Leuschner F, Rauch PJ, Ueno T, Gorbatov R, Marinelli B, Lee WW et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med 2012; 209: 123-137.
21. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J ExpMed 2007; 204: 3037-3047.
22. Adutler-Lieber S, Ben-Mordechai T, Naftali-Shani N, Asher E, Loberman D, Raanani E et al. Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. J Cardiovasc Pharmacol Therapeutics 2013; 18: 78-86.
23. Kim YS, Ahn Y, Kwon JS, Cho YK, Jeong MH, Cho JG et al. Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury. Cells Tissues Organs 2012; 195: 428-442.
24. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeriainduced macrophages. Science 1993; 260: 547-549.
25. de Jager SC, Bot I, Kraaijeveld AO, Korporaal SJ, Bot M, van Santbrink PJ et al. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation. Arteriosclerosis Thrombosis Vasc Biol 2013; 33: e75-e83.
26. Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/ tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005; 115: 1-20.
27. Kim CH. Chemokine-chemokine receptor network in immune cell trafficking. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4: 343-361.